Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892042921> ?p ?o ?g. }
- W2892042921 endingPage "199.e19" @default.
- W2892042921 startingPage "186" @default.
- W2892042921 abstract "Mutations or aberrant upregulation of EZH2 occur frequently in human cancers, yet clinical benefits of EZH2 inhibitor (EZH2i) remain unsatisfactory and limited to certain hematological malignancies. We profile global posttranslational histone modification changes across a large panel of cancer cell lines with various sensitivities to EZH2i. We report here oncogenic transcriptional reprogramming mediated by MLL1's interaction with the p300/CBP complex, which directs H3K27me loss to reciprocal H3K27ac gain and restricts EZH2i response. Concurrent inhibition of H3K27me and H3K27ac results in transcriptional repression and MAPK pathway dependency in cancer subsets. In preclinical models encompassing a broad spectrum of EZH2-aberrant solid tumors, a combination of EZH2 and BRD4 inhibitors, or a triple-combination including MAPK inhibition display robust efficacy with very tolerable toxicity. Our results suggest an attractive precision treatment strategy for EZH2-aberrant tumors on the basis of tumor-intrinsic MLL1 expression and concurrent inhibition of epigenetic crosstalk and feedback MAPK activation." @default.
- W2892042921 created "2018-09-27" @default.
- W2892042921 creator A5002591086 @default.
- W2892042921 creator A5029508998 @default.
- W2892042921 creator A5033268397 @default.
- W2892042921 creator A5033315143 @default.
- W2892042921 creator A5033669250 @default.
- W2892042921 creator A5041108474 @default.
- W2892042921 creator A5045136663 @default.
- W2892042921 creator A5046542455 @default.
- W2892042921 creator A5054043511 @default.
- W2892042921 creator A5055455443 @default.
- W2892042921 creator A5057713623 @default.
- W2892042921 creator A5060848619 @default.
- W2892042921 creator A5061074781 @default.
- W2892042921 creator A5063800558 @default.
- W2892042921 creator A5066293115 @default.
- W2892042921 creator A5076988030 @default.
- W2892042921 creator A5086770255 @default.
- W2892042921 creator A5089348951 @default.
- W2892042921 creator A5091105051 @default.
- W2892042921 date "2018-09-01" @default.
- W2892042921 modified "2023-10-15" @default.
- W2892042921 title "Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors" @default.
- W2892042921 cites W1491356667 @default.
- W2892042921 cites W1966429292 @default.
- W2892042921 cites W1966815678 @default.
- W2892042921 cites W1970888745 @default.
- W2892042921 cites W1978842703 @default.
- W2892042921 cites W1981421409 @default.
- W2892042921 cites W1987937498 @default.
- W2892042921 cites W1993391636 @default.
- W2892042921 cites W1995275377 @default.
- W2892042921 cites W1996487270 @default.
- W2892042921 cites W2003872705 @default.
- W2892042921 cites W2004380688 @default.
- W2892042921 cites W2013149980 @default.
- W2892042921 cites W2014359105 @default.
- W2892042921 cites W2017492512 @default.
- W2892042921 cites W2022473934 @default.
- W2892042921 cites W2024373518 @default.
- W2892042921 cites W2031885286 @default.
- W2892042921 cites W2035208208 @default.
- W2892042921 cites W2048122601 @default.
- W2892042921 cites W2051541007 @default.
- W2892042921 cites W2055617812 @default.
- W2892042921 cites W2064261519 @default.
- W2892042921 cites W2070604281 @default.
- W2892042921 cites W2096149923 @default.
- W2892042921 cites W2100086304 @default.
- W2892042921 cites W2106785524 @default.
- W2892042921 cites W2113035823 @default.
- W2892042921 cites W2125496315 @default.
- W2892042921 cites W2146411852 @default.
- W2892042921 cites W2148741118 @default.
- W2892042921 cites W2171439874 @default.
- W2892042921 cites W2190015925 @default.
- W2892042921 cites W2232564189 @default.
- W2892042921 cites W2264682687 @default.
- W2892042921 cites W2294583975 @default.
- W2892042921 cites W2395887422 @default.
- W2892042921 cites W2400261832 @default.
- W2892042921 cites W2410865989 @default.
- W2892042921 cites W2413957525 @default.
- W2892042921 cites W2513480194 @default.
- W2892042921 cites W2520339276 @default.
- W2892042921 cites W2604847558 @default.
- W2892042921 cites W2606835938 @default.
- W2892042921 cites W2607299002 @default.
- W2892042921 cites W2609672257 @default.
- W2892042921 cites W2625559053 @default.
- W2892042921 cites W2739001429 @default.
- W2892042921 cites W2747620054 @default.
- W2892042921 doi "https://doi.org/10.1016/j.cell.2018.08.058" @default.
- W2892042921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30220457" @default.
- W2892042921 hasPublicationYear "2018" @default.
- W2892042921 type Work @default.
- W2892042921 sameAs 2892042921 @default.
- W2892042921 citedByCount "149" @default.
- W2892042921 countsByYear W28920429212019 @default.
- W2892042921 countsByYear W28920429212020 @default.
- W2892042921 countsByYear W28920429212021 @default.
- W2892042921 countsByYear W28920429212022 @default.
- W2892042921 countsByYear W28920429212023 @default.
- W2892042921 crossrefType "journal-article" @default.
- W2892042921 hasAuthorship W2892042921A5002591086 @default.
- W2892042921 hasAuthorship W2892042921A5029508998 @default.
- W2892042921 hasAuthorship W2892042921A5033268397 @default.
- W2892042921 hasAuthorship W2892042921A5033315143 @default.
- W2892042921 hasAuthorship W2892042921A5033669250 @default.
- W2892042921 hasAuthorship W2892042921A5041108474 @default.
- W2892042921 hasAuthorship W2892042921A5045136663 @default.
- W2892042921 hasAuthorship W2892042921A5046542455 @default.
- W2892042921 hasAuthorship W2892042921A5054043511 @default.
- W2892042921 hasAuthorship W2892042921A5055455443 @default.
- W2892042921 hasAuthorship W2892042921A5057713623 @default.
- W2892042921 hasAuthorship W2892042921A5060848619 @default.
- W2892042921 hasAuthorship W2892042921A5061074781 @default.